News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1981 results

Fed Circuit affirms GSK $107m patent loss

US20-11-2020Sarah Morgan

The US Court of Appeals for the Federal Circuit rejected GlaxoSmithKline’s challenge of a $89.7 million verdict which found the drugmaker had infringed a dry-powder inhaler patent.

Medicure and Nexus agree Aggrastat generic licence

US20-11-2020Rory O'Neill

US cardiovascular therapies company Medicure has settled a patent infringement dispute with rival Nexus Pharmaceuticals.

Third Circuit under fire over FTC v AbbVie ruling

US18-11-2020Rory O'Neill

The US Federal Trade Commission and AbbVie both want a federal appeals court to rehear a lawsuit accusing the drug company of quashing competition through sham patent litigation.

GSK, Amgen want SCOTUS to protect genus claims

US18-11-2020Rory O'Neill

Patent law experts and pharmaceutical companies have lent their support to Merck Sharp & Dohme in its effort to confirm the patent-eligibility of genus claims at the US Supreme Court.

Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen

US18-11-2020

Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen.

Baxter sues B.Braun in revived kidney treatment patent dispute

Germany16-11-2020

American healthcare multinational Baxter has accused B.Braun of patent infringement and fraudulent misrepresentation in an on-going dispute over products used to treat acute kidney injury.

FDA to grant licence to Chinese-owned Advion for COVID-19 diagnostic patent

US13-11-2020

The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19.

Fed Circuit cancels Bard patent loss

US12-11-2020Rory O'Neill

The US Court of Appeals for the Federal Circuit has cancelled a lower court ruling holding that a Bard patent for vascular access device was both not infringed and patent-ineligible.

Allied BioScience sues ex-CEO for holding IP hostage

US12-11-2020Muireann Bolger

Allied BioScience has accused its former CEO of holding the company's IP, including inventions relating to its COVID-19 antiviral disinfectant, to ransom so he can demand an unfair amount of compensation.

Milestone COVID-19 vaccine offers 90% protection

International10-11-2020Muireann Bolger

A coronavirus vaccine unveiled by pharmaceutical companies Pfizer and BioNTech can potentially prevent more than 90% of people from getting COVID-19, it has been announced.

Showing 1 to 10 of 1981 results

LSIPR